Alzheimerfonden interviews CEO Kristina Torfgård
Date: 2024-02-06
Alzinovas CEO Kristina Torfgård interviewed by Alzheimerfonden regarding the latest clinical development and results from the phase 1b study with the vaccine candidate ALZ-101.
We would like to thank the Alzheimerfonden for recognizing our efforts and for supporting research that aims to change lives.